Skip to main content
OpenTrials

Clinical trial condition

HIV Infections

Explore clinical trials studying HIV Infections. Study availability and eligibility vary by location and protocol.

3,320 public trials 107 recruiting studies
Refine in advanced search Browse all conditions

HIV Infections trial results

Completed

HIV-1-Gag Conserved-Element DNA Vaccine (p24CE) Vaccine Study

NCT03560258

Conditions
Blood-Borne Infections, Communicable Diseases, Genital Diseases, +11 more
Locations
  • Alabama CRS Birmingham, Alabama, United States
  • UCLA CARE Center CRS Los Angeles, California, United States
  • Ucsf Hiv/Aids Crs San Francisco, California, United States
  • Northwestern University CRS Chicago, Illinois, United States
View all 15 locations
View Trial Details
Completed

Evaluating the Safety and Immunogenicity of Env (A,B,C,A/E)/Gag (C) DNA and gp120 (A,B,C,A/E) Protein/GLA-SE HIV Vaccines, Given Individually or Co-administered, in Healthy, HIV-1-Uninfected Adults

NCT03409276

Conditions
Blood-Borne Infections, Communicable Diseases, Genital Diseases, +11 more
Locations
  • Alabama CRS Birmingham, Alabama, United States
  • The Hope Clinic of the Emory Vaccine Center CRS Decatur, Georgia, United States
  • Fenway Health (FH) CRS Boston, Massachusetts, United States
  • University of Rochester Vaccines to Prevent HIV Infection CRS Rochester, New York, United States
View Trial Details
Completed

Integrase and Maraviroc Intensification in Neurocognitive Dysfunction (InMIND)

NCT02519777

Conditions
Blood-Borne Infections, Communicable Diseases, Genital Diseases, +11 more
Locations
  • UCLA CARE Center CRS Los Angeles, California, United States
  • UCSD Antiviral Research Center CRS San Diego, California, United States
  • Harbor-UCLA CRS Torrance, California, United States
  • Whitman-Walker Health CRS Washington D.C., District of Columbia, United States
View all 30 locations
View Trial Details
Completed

An Observational Study of Long-term Outcomes of HIV-1 Infection in Persons Who Become HIV-1 Infected After Enrollment in HIV-1 Vaccine Trials

NCT03337906

Conditions
Blood-Borne Infections, Communicable Diseases, Genital Diseases, +11 more
Locations
  • Alabama Vaccine CRS Birmingham, Alabama, United States
  • Bridge HIV CRS San Francisco, California, United States
  • The Hope Clinic of the Emory Vaccine Center CRS Decatur, Georgia, United States
  • UIC Project WISH CRS Chicago, Illinois, United States
View all 21 locations
View Trial Details
Completed

A Study of GSK1349572 Versus Raltegravir (RAL) With Investigator Selected Background Regimen in Antiretroviral-Experienced, Integrase Inhibitor-Naive Adults

NCT01231516

Conditions
Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +14 more
Locations
  • GSK Investigational Site Birmingham, Alabama, United States
  • GSK Investigational Site Phoenix, Arizona, United States
  • GSK Investigational Site Little Rock, Arkansas, United States
  • GSK Investigational Site Bakersfield, California, United States
View all 180 locations
View Trial Details

Related conditions